The new variant might be able to dodge one of the PCR tests authorised in the US, the FDA says.
An evolving virus demands innovative diagnostic technologies.
And consolidation in the diagnostics space is only just beginning.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.